Dexcom (DXCM) Assets Growth (5y) (2015 - 2026)
Powered by 
Analysis
Dexcom (DXCM) Assets Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.63 Bn | 178.03 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn |
| 3 | Medtronic | 118.51 Bn | 109.69 Bn | 6.34 Bn |
| 4 | Stryker | 106.53 Bn | 103.06 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.52 Bn | 65.98 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.57 Bn | 45.32 Bn | 1.35 Bn |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.47% |
| Mar 31, 2026 | 8.61% |
| Dec 31, 2025 | 8.12% |
| Sep 30, 2025 | 14.37% |
| Jun 30, 2025 | 15.78% |
| Mar 31, 2025 | 22.50% |
| Dec 31, 2024 | 22.04% |
| Sep 30, 2024 | 23.79% |
| Jun 30, 2024 | 26.90% |
| Mar 31, 2024 | 26.85% |
| Dec 31, 2023 | 26.74% |
| Sep 30, 2023 | 42.71% |
| Jun 30, 2023 | 46.59% |
| Mar 31, 2023 | 43.81% |
| Dec 31, 2022 | 42.92% |
| Sep 30, 2022 | 42.19% |
| Jun 30, 2022 | 45.66% |
| Mar 31, 2022 | 61.02% |
| Dec 31, 2021 | 65.05% |
| Sep 30, 2021 | 67.53% |